Christopher Sullivan
Director Financiero/CFO en AVALO THERAPEUTICS, INC. .
Fortuna: 75 $ al 30/04/2024
Perfil
Christopher Sullivan is currently the Chief Financial Officer at Avalo Therapeutics, Inc. He previously worked as a Senior Manager at Ernst & Young LLP.
Additionally, he served as a Controller at OpGen, Inc. from 2015 to 2017 and at Sucampo Pharmaceuticals LLC from 2017 to 2018.
Mr. Sullivan completed his undergraduate degree at the University of Maryland.
Participaciones conocidas en empresas públicas
Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
---|---|---|---|---|
AVALO THERAPEUTICS INC
0.00% | 27/03/2024 | 5 ( 0.00% ) | 75 $ | 30/04/2024 |
Cargos activos de Christopher Sullivan
Empresas | Cargo | Inicio |
---|---|---|
AVALO THERAPEUTICS, INC. | Director Financiero/CFO | 14/02/2022 |
Antiguos cargos conocidos de Christopher Sullivan.
Empresas | Cargo | Fin |
---|---|---|
SUCAMPO PHARMACEUTICALS, INC. | Comptroller/Controller/Auditor | 01/04/2018 |
OPGEN, INC. | Comptroller/Controller/Auditor | 01/08/2017 |
Ernst & Young LLP
Ernst & Young LLP Miscellaneous Commercial ServicesCommercial Services Ernst & Young LLP engages in the provision of accounting, assurance, tax, transaction, and advisory services. It specializes in the actuarial, analytics and big data, cyber security, accounting compliance and reporting, center for board matters, international financial reporting standards, country tax advisory, global trade, tax accounting, and climate change and sustainability. The company was founded in 1989 and is headquartered in New York, NY. | Corporate Officer/Principal | - |
Formación de Christopher Sullivan.
University of Maryland | Undergraduate Degree |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
Empresas cotizadas | 2 |
---|---|
AVALO THERAPEUTICS, INC. | Health Technology |
OPGEN, INC. | Commercial Services |
Empresas privadas | 2 |
---|---|
Sucampo Pharmaceuticals, Inc.
Sucampo Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Sucampo Pharmaceuticals, Inc. is a biopharmaceutical company. It engages in the development, identification, acquisition, and delivery of innovative pharmaceutical products. The company was founded by Ryuji Ueno and Sachiko Kuno on December 5, 1996 and is headquartered in Bethesda, MD. | Health Technology |
Ernst & Young LLP
Ernst & Young LLP Miscellaneous Commercial ServicesCommercial Services Ernst & Young LLP engages in the provision of accounting, assurance, tax, transaction, and advisory services. It specializes in the actuarial, analytics and big data, cyber security, accounting compliance and reporting, center for board matters, international financial reporting standards, country tax advisory, global trade, tax accounting, and climate change and sustainability. The company was founded in 1989 and is headquartered in New York, NY. | Commercial Services |
- Bolsa de valores
- Insiders
- Christopher Sullivan